The MPC-11 Cell Line is a valuable tool in cancer research, specifically focused on immunotherapy and PD (Pharmacodynamics) assessment. With its unique properties and compatibility with BALB/c mice, this mouse plasma cell myeloma model holds great potential for studying anti-cancer immunotherapeutic efficacy. CrownBio offers the MPC-11 model for subcutaneous and systemic (i.v. injected) applications, providing researchers with versatile options for their studies.
MPC-11 is a mouse plasma cell myeloma with a H-2d haplotype. This cell line can be grown in BALB/c mice and is fit for the assessment of anti-cancer immunoterapeutic efficacy and PD. At CrownBio, the MPC-11 model is available subcutaneously and systemically (i.v. injected).
Summary | |
---|---|
Cancer Type | Myeloma |
Subtype | N/A |
Mouse Strain | BALB/c |
TMA | TMA-CP-SY-008 |